Adeel Khan, M.D., M.P.H., M.S., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He is also an Assistant Professor in the Peter O’Donnell Jr. School of Public Health. He specializes in myeloma, amyloidosis, and Waldenström macroglobulinemia and serves as the Director of Myeloma Epidemiology Research and Clinical Director of the Monoclonal Gammopathy Precursor Clinic. He treats the full spectrum of myeloma and monoclonal gammopathies from MGUS to CART, bispecifics, and clinical trials.

Dr. Khan earned his medical degree with special distinction at the University of Michigan in Ann Arbor, Michigan, while also obtaining a master’s degree in public health from Harvard University. He performed a residency in internal medicine at the Cleveland Clinic and Lerner College of Medicine in Cleveland, Ohio. After serving as a hospitalist at Massachusetts General Hospital and an instructor at Harvard Medical School and concurrently obtaining a master's degree in epidemiology from Columbia University, he gained advanced training in hematology and oncology through a fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School.

Board-certified in internal medicine and hematology, he joined the UT Southwestern faculty in 2022.

Dr. Khan’s research interests include myeloma and other monoclonal gammopathies, as well as cancer epidemiology. He has delivered numerous presentations at large national conferences and published peer-reviewed articles related to his areas of expertise.

He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, and the American Public Health Association.